LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 7 of total 7

Search options

  1. Article ; Online: Delayed Leukoreduction of whole blood with a platelet-sparing filter to increase low-titer group O whole blood production in the United States.

    Wellington, Michael / Feldman, Tamar Perla / Cleeton, Stephanie / Sawyer, Sherrie / Brown, Bethany L

    Transfusion

    2023  Volume 63 Suppl 3, Page(s) S177–S188

    Abstract: Background: Demand for low-titer Group O whole blood (LTOWB) is increasing for trauma. The whole blood (WB) platelet-sparing (WB-SP) filter enables leukoreduction (LR) while retaining platelet quantity and function; however, in the United States WB must ...

    Abstract Background: Demand for low-titer Group O whole blood (LTOWB) is increasing for trauma. The whole blood (WB) platelet-sparing (WB-SP) filter enables leukoreduction (LR) while retaining platelet quantity and function; however, in the United States WB must be filtered and placed in the cold within 8 h of collection. A longer processing window would facilitate improved logistics and supply of LR-WB to meet the growing medical need. This study evaluated the impact of increasing filtration timing from <8 h to <12 h on the quality of LR-WB.
    Study design and methods: Thirty WB units were collected from healthy donors. Control units were filtered within 8 h and test units within 12 h of collection. WB was tested throughout 21 days of storage. Hemolysis, WBC content, component recovery, and 25 additional markers of WB quality were tested including hematologic and metabolic markers, RBC morphology, aggregometry, thromboelastography, and p-selectin.
    Results: There were 0 failures for residual WBC content, hemolysis, or pH, and no differences in component recovery between arms. Few differences in metabolic parameters were observed, but the small effect size suggests these are not clinically significant. Trends throughout storage were similar and filtration timing did not impact hematological parameters, platelet activation and aggregation, or hemostatic capacity.
    Conclusion: Our studies showed that extending filtration timing from 8 to 12 h from the collection does not significantly impact the quality of LR-WB. Characterization of the platelets demonstrated that storage lesions were not exacerbated. Extending the time from collection to filtration will improve LTOWB inventory in the United States.
    MeSH term(s) Humans ; Hemolysis ; Blood Preservation ; Blood Platelets/metabolism ; Platelet Activation ; Leukocyte Reduction Procedures
    Language English
    Publishing date 2023-04-20
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 208417-x
    ISSN 1537-2995 ; 0041-1132
    ISSN (online) 1537-2995
    ISSN 0041-1132
    DOI 10.1111/trf.17372
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Temperature cycling during platelet cold storage improves in vivo recovery and survival in healthy volunteers.

    Vostal, Jaroslav G / Gelderman, Monique P / Skripchenko, Andrey / Xu, Fei / Li, Ying / Ryan, Johannah / Cheng, Chunrong / Whitley, Pam / Wellington, Michael / Sawyer, Sherrie / Hanley, Shalene / Wagner, Stephen J

    Transfusion

    2017  Volume 58, Issue 1, Page(s) 25–33

    Abstract: Background: Room temperature (RT) storage of platelets (PLTs) can support bacterial proliferation in contaminated units, which can lead to transfusion-transmitted septic reactions. Cold temperature storage of PLTs could reduce bacterial proliferation ... ...

    Abstract Background: Room temperature (RT) storage of platelets (PLTs) can support bacterial proliferation in contaminated units, which can lead to transfusion-transmitted septic reactions. Cold temperature storage of PLTs could reduce bacterial proliferation but cold exposure produces activation-like changes in PLTs and leads to their rapid clearance from circulation. Cold-induced changes are reversible by warming and periodic rewarming during cold storage (temperature cycling [TC]) has been proposed to alleviate cold-induced reduction in PLT circulation.
    Study design and methods: A clinical trial in healthy human volunteers was designed to compare in vivo recovery, survival, and area under the curve (AUC) of radiolabeled autologous apheresis PLTs stored for 7 days at RT or under TC or cold conditions. Paired comparisons of RT versus TC and TC versus cold PLTs were conducted.
    Results: Room temperature PLTs had in vivo recovery of 55.7 ± 13.9%, survival of 161.3 ± 28.8 hours, and AUC of 5031.2 ± 1643.3. TC PLTs had recovery of 42.6 ± 16.4%, survival of 48.1 ± 14.4% hours, and AUC of 1331.3 ± 910.2 (n = 12, p < 0.05). In a separate paired comparison, cold PLTs had recovery of 23.1 ± 8.8%, survival of 33.7 ± 14.7 hours, and AUC of 540.2 ± 229.6 while TC PLTs had recovery of 36.5 ± 12.9%, survival of 49.0 ± 17.3 hours, and AUC of 1164.3 ± 622.2 (n = 4, AUC had p < 0.05).
    Conclusion: TC storage for 7 days produced PLTs with better in vivo circulation kinetics than cold storage but is not equivalent to RT storage.
    MeSH term(s) Adenosine Diphosphate/pharmacology ; Annexin A5/metabolism ; Area Under Curve ; Blood Platelets/cytology ; Blood Platelets/drug effects ; Blood Preservation/methods ; Blood Transfusion, Autologous ; Cell Shape ; Cell Survival ; Collagen/pharmacology ; Cryopreservation/methods ; Healthy Volunteers ; Humans ; Hydrogen-Ion Concentration ; Organ Preservation Solutions/chemistry ; P-Selectin/blood ; Platelet Activation/drug effects ; Platelet Glycoprotein GPIb-IX Complex/analysis ; Platelet Transfusion ; Temperature ; Time Factors
    Chemical Substances Annexin A5 ; Organ Preservation Solutions ; P-Selectin ; Platelet Glycoprotein GPIb-IX Complex ; Adenosine Diphosphate (61D2G4IYVH) ; Collagen (9007-34-5)
    Language English
    Publishing date 2017-11-08
    Publishing country United States
    Document type Clinical Trial ; Comparative Study ; Journal Article ; Research Support, U.S. Gov't, Non-P.H.S. ; Research Support, U.S. Gov't, P.H.S.
    ZDB-ID 208417-x
    ISSN 1537-2995 ; 0041-1132
    ISSN (online) 1537-2995
    ISSN 0041-1132
    DOI 10.1111/trf.14392
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article: Automated collection of double red blood cell units with a variable-volume separation chamber.

    Aubuchon, James P / Dumont, Larry J / Herschel, Louise / Roger, Jill / Beddard, Rachel L / Taylor, Harry L / Whitley, Pamela H / Sawyer, Sherrie L / Graminske, Sharon / Martinson, Karen / Dora, Ross / Heldke, Sybil / Adamson, John / Rose, Leslie E

    Transfusion

    2008  Volume 48, Issue 1, Page(s) 147–152

    Abstract: Background: Automated collection of blood components offers multiple advantages and has prompted development of portable devices. This study sought to document the biochemical and hematologic properties and in vivo recovery of red cells (RBCs) collected ...

    Abstract Background: Automated collection of blood components offers multiple advantages and has prompted development of portable devices. This study sought to document the biochemical and hematologic properties and in vivo recovery of red cells (RBCs) collected via a new device that employed a variable-volume centrifugal separation chamber.
    Study design and methods: Normal subjects (n = 153) donated 2 units of RBCs via an automated blood collection system (Cymbal, Haemonetics). Procedures were conducted with wall outlet power (n = 49) or the device's battery source (n = 104). Units were collected with or without leukoreduction filtration and were stored in AS-3 for 42 days. The units were assessed via standard biochemical and hematologic tests before and after storage, and 24 leukoreduced (LR) and 24 non-LR RBCs were radiolabeled on Day 42 with Na(2)(51)CrO(4) for autologous return to determine recovery at 24 hours with concomitant determination of RBC volume via infusion of (99m)Tc-labeled fresh RBCs.
    Results: Two standard RBC units (targeted to contain 180 mL of RBCs plus 100 mL of AS-3) could be collected in 35.7 +/- 2.0 minutes (n = 30) or 40.3 +/- 2.7 minutes for LR RBCs (n = 92). An additional 31 collections were conducted successfully with intentional filter bypassing. RBC units contained 104 +/- 4.1 percent of their targeted volumes (170-204 mL of RBCs), and LR RBCs contained 92 percent of non-LR RBCs' hemoglobin. All LR RBCs contained less than 1 x 10(6) white blood cells. Mean hemolysis was below 0.8 percent (Day 42) for all configurations. Adenosine triphosphate was well preserved. Mean recovery was 82 +/- 4.9 percent for RBCs and 84 +/- 7.0 percent for LR RBCs.
    Conclusions: The Cymbal device provided quick and efficient collection of 2 RBC units with properties meeting regulatory requirements and consistent with good clinical utility.
    MeSH term(s) Adenosine Triphosphate/analysis ; Automation ; Blood Component Removal/instrumentation ; Cell Separation/instrumentation ; Cell Separation/methods ; Equipment Design ; Erythrocyte Count ; Erythrocyte Transfusion ; Erythrocytes ; Hemoglobins/analysis ; Hemolysis ; Humans ; Leukocyte Count ; Leukocyte Reduction Procedures
    Chemical Substances Hemoglobins ; Adenosine Triphosphate (8L70Q75FXE)
    Language English
    Publishing date 2008-01
    Publishing country United States
    Document type Evaluation Studies ; Journal Article
    ZDB-ID 208417-x
    ISSN 1537-2995 ; 0041-1132
    ISSN (online) 1537-2995
    ISSN 0041-1132
    DOI 10.1111/j.1537-2995.2007.01492.x
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article: Seven-day storage of single-donor platelets: recovery and survival in an autologous transfusion study.

    Dumont, Larry J / AuBuchon, James P / Whitley, Pamela / Herschel, Louise H / Johnson, Adrienne / McNeil, Deanna / Sawyer, Sherrie / Roger, Jill C

    Transfusion

    2002  Volume 42, Issue 7, Page(s) 847–854

    Abstract: Background: Bacterial screening may effectively reduce the morbidity and mortality risk associated with extended storage of platelets. Platelet viability then becomes the primary determinant of acceptable storage time. This study evaluates the ... ...

    Abstract Background: Bacterial screening may effectively reduce the morbidity and mortality risk associated with extended storage of platelets. Platelet viability then becomes the primary determinant of acceptable storage time. This study evaluates the effectiveness of platelets stored in plasma for 7 days.
    Study design and methods: WBC-reduced, single-donor platelets (n = 24) were collected and stored by standard methods at two sites. Standard in vitro platelet biochemical and functional parameters were monitored over the storage period. On Days 5 and 7 of storage, platelets were alternately labeled with 51Cr and (111)In and returned to the subject, and recovery and survival were determined.
    Results: Component pH(22 degrees C) was maintained in the range 6.2 to 7.61 through 7 days and did not detrimentally affect either in vitro or in vivo outcomes. In vitro platelet characteristics were adequately maintained over 7 days. Day 5 platelets had better recovery (63.0 +/- 4.36 vs. 53.9 +/- 4.36%, p < 0.0001) and survival (161 +/- 8.1 vs. 133 +/- 8.1 hr, p = 0.006) than Day 7 platelets adjusting for radioisotope, center, and donor effects.
    Conclusion: Although declines in recovery and survival were noted, these are less than used previously to gain licensure of 7-day storage and are unlikely to be clinically significant. Extension of storage to 7 days could be implemented with bacterial screening methods to select out contaminated components without a significant effect on the platelet efficacy compared to 5-day components.
    MeSH term(s) Blood Platelets/cytology ; Blood Platelets/metabolism ; Blood Preservation/methods ; Blood Preservation/standards ; Blood Transfusion, Autologous/methods ; Blood Transfusion, Autologous/standards ; Cell Survival ; Female ; Humans ; Hydrogen-Ion Concentration ; Lactic Acid/metabolism ; Male ; Platelet Function Tests ; Platelet Transfusion/methods ; Platelet Transfusion/standards ; Radioisotopes ; Time Factors
    Chemical Substances Radioisotopes ; Lactic Acid (33X04XA5AT)
    Language English
    Publishing date 2002-07
    Publishing country United States
    Document type Clinical Trial ; Comparative Study ; Journal Article ; Multicenter Study ; Randomized Controlled Trial ; Research Support, Non-U.S. Gov't
    ZDB-ID 208417-x
    ISSN 1537-2995 ; 0041-1132
    ISSN (online) 1537-2995
    ISSN 0041-1132
    DOI 10.1046/j.1537-2995.2002.00147.x
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article: Autologous transfusion recovery of WBC-reduced high-concentration platelet concentrates.

    Dumont, Larry J / Beddard, Rachel / Whitley, Pamela / Johnson, Adrienne / McNeil, Deanna / Sawyer, Sherrie / Elfath, M Dean

    Transfusion

    2002  Volume 42, Issue 10, Page(s) 1333–1339

    Abstract: Background: This study evaluates the recovery and survival of high-concentration platelets (HCPs) compared to standard apheresis platelets (APCs) in a double-label autologous human system.: Methods: Nine HCP units paired with APC units were stored, ... ...

    Abstract Background: This study evaluates the recovery and survival of high-concentration platelets (HCPs) compared to standard apheresis platelets (APCs) in a double-label autologous human system.
    Methods: Nine HCP units paired with APC units were stored, labeled with either 51Cr and 111In, and returned, and recovery and survival were determined. Standard in vitro platelet biochemical and functional parameters were monitored over the storage period and evaluated in a secondary analysis.
    Results: Three each HCP units containing more than 2.2 x 10(11), 1.5 x 10(11) to 2.1 x 10(11), and 0.8 x 10(11) to 1.1 x 10(11) platelets in 59.4 +/- 2.5 mL were stored for 1, 2, or 5 days, respectively, and simultaneously with matched APC units (3.8 x 10(11) platelets, 282 mL). Recoveries were 72.3 +/- 8.6, 60.8 +/- 14.6, and 52.5 +/- 6.7 percent for HCPs, respectively; and 59.4 +/- 6.4 percent for APCs (p=0.37). HCP survivals were 202.0 +/- 14.9, 204.9 +/- 10.2, and 162.6 +/- 17.0 hours; APC survivals were 155.4 +/- 20.3 hours (p=0.001). Secondary analysis with P-selectin added as a predictor in the model resulted in significant difference in recoveries for Day 1 HCPs versus Day 5 APCs (p=0.024) with no difference shown for HCPs on Days 2 or 5 versus APCs. No significant difference was found in survival (p=0.16).
    Conclusion: HCPs may be stored 24 hours for high yield, 48 hours for intermediate yield, and up to 5 days for yields less than 1.6 x 10(11) platelets per bag with equivalent to superior recovery and survival of platelets in the autologous transfusion model compared to APCs.
    MeSH term(s) Blood Cell Count ; Blood Preservation ; Blood Transfusion, Autologous ; Graft Survival ; Humans ; Hydrogen-Ion Concentration ; Leukocytes ; P-Selectin/analysis ; Platelet Transfusion ; Plateletpheresis ; Time Factors
    Chemical Substances P-Selectin
    Language English
    Publishing date 2002-10
    Publishing country United States
    Document type Clinical Trial ; Comparative Study ; Controlled Clinical Trial ; Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 208417-x
    ISSN 1537-2995 ; 0041-1132
    ISSN (online) 1537-2995
    ISSN 0041-1132
    DOI 10.1046/j.1537-2995.2002.00222.x
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article: Reevaluation of the resting time period when preparing whole blood-derived platelet concentrates with the platelet-rich plasma method.

    Moroff, Gary / Kline, Linda / Dabay, Michelle / Hunter, Suzanne / Johnson, Adrienne / McNeil, Deanna / Nixon, Jan / Sawyer, Sherrie / Taylor, Harry / Whitley, Pam / Wahab, Fawzi / Murphy, Scott

    Transfusion

    2006  Volume 46, Issue 4, Page(s) 572–577

    Abstract: Background: The resting of platelet (PLT) pellets during the preparation of whole blood-derived PLT concentrates (PCs) is considered an essential step. A reevaluation of the rest period was conducted because preparation and storage conditions have been ... ...

    Abstract Background: The resting of platelet (PLT) pellets during the preparation of whole blood-derived PLT concentrates (PCs) is considered an essential step. A reevaluation of the rest period was conducted because preparation and storage conditions have been modified during the past 20 years.
    Study design and methods: A two-site in vitro study (Study 1) was conducted with rest times of 0 to 5 minutes, 1 hour, and 4 hours (n = 31-33 per rest period). Leukoreduced PCs were stored for 5 days. A second study (Study 2) measuring in vivo viability was conducted at a third site (14 paired studies). PCs were prepared from 2 units of whole blood on the same day to simultaneously compare viability following storage and radioisotopic labeling.
    Results: In Study 1, comparable in vitro parameters and swirling were observed with the three rest periods. The mean (+/-1 SD) values after storage for the extent of shape change and hypotonic stress parameters were 0 to 5 minutes, 16.7 +/- 7.2 and 66.0 +/- 15.7%; 1 hour, 19.1 +/- 6.9 and 69.3 +/- 17.9%; and 4 hours, 17.6 +/- 5.5 and 64.1 +/- 11.3%. In Study 2, the in vivo recovery was 49.9 +/- 15.3 and 50.9 +/- 20.2% with 0- to 5-minute and 1-hour rest periods, respectively. The corresponding survival time was 111.2 +/- 50.7 and 114.9 +/- 43.8 hours.
    Conclusion: These studies indicate comparable in vitro and in vivo viability properties with 0- to 5-minute and 1-hour rest periods and at 4 hours (in vitro only).
    MeSH term(s) Anticoagulants ; Blood Platelets/cytology ; Blood Preservation/methods ; Carbon Dioxide/blood ; Cell Survival ; Humans ; In Vitro Techniques ; Oxygen/blood ; Platelet Count ; Platelet Transfusion/methods ; Time Factors
    Chemical Substances Anticoagulants ; Carbon Dioxide (142M471B3J) ; Oxygen (S88TT14065)
    Language English
    Publishing date 2006-04
    Publishing country United States
    Document type Journal Article
    ZDB-ID 208417-x
    ISSN 1537-2995 ; 0041-1132
    ISSN (online) 1537-2995
    ISSN 0041-1132
    DOI 10.1111/j.1537-2995.2006.00756.x
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article: Extended storage of AS-1 and AS-3 leukoreduced red blood cells for 15 days after deglycerolization and resuspension in AS-3 using an automated closed system.

    Bandarenko, Nicholas / Hay, Shauna N / Holmberg, Jerry / Whitley, Pam / Taylor, Harry L / Moroff, Gary / Rose, Leslie / Kowalsky, Richard / Brumit, Marla / Rose, Michael / Sawyer, Sherrie / Johnson, Adrienne / McNeil, Deanna / Popovsky, Mark A

    Transfusion

    2004  Volume 44, Issue 11, Page(s) 1656–1662

    Abstract: Background: The utilization of cryopreserved red blood cell (RBC) units had been limited by a maximum postdeglycerolization storage of 24 hours at 1 to 6 degrees C until the recent development of a closed system for the glycerolization and ... ...

    Abstract Background: The utilization of cryopreserved red blood cell (RBC) units had been limited by a maximum postdeglycerolization storage of 24 hours at 1 to 6 degrees C until the recent development of a closed system for the glycerolization and deglycerolization process.
    Study design and methods: Sixty leukoreduced additive solution (AS), AS-1 (n = 30) and AS-3 (n = 30) RBC units from 500-mL whole blood (WB) collections were stored for 6 days, glycerolized, frozen at -70 +/- 5 degrees C for at least 14 days, thawed, deglycerolized, and stored for 15 days at 1 to 6 degrees C. Glycerolization and deglycerolization were performed with the ACP 215. In-vitro variables were tested before glycerolization, on Day 0, and Day 15 after deglycerolization storage. Forty donors were assessed for double-label 24-hour percent recovery, and T1/2 survival time was measured for 20 donors.
    Results: Postdeglycerolization mean +/- standard deviation in-vitro RBC mass recoveries were 93 +/- 5 percent for AS-1 and 95 +/- 4 percent for AS-3. Mean hemoglobin +/- standard deviation after deglycerolization was 50.5 +/- 5.5g for AS-1 and 50.1 +/- 3.5g for AS-3. Mean hemolysis (Day 15) was 0.36 +/- 0.11 percent for AS-1 and 0.38 +/- 0.13 percent for AS-3. Double-label 24-hour in-vivo recoveries were 82.5 +/- 7.8 percent for AS-1 and 81.4 +/- 7.1 percent for AS-3. The 51Cr T1/2 value was 41.8 +/- 3.97 for AS-1 and 40.6 +/- 7.11 for AS-3. Other in-vitro variables were as expected.
    Conclusion: Leukoreduced AS-1 and AS-3 RBCs after frozen storage at -70 +/- 5 degrees C can be stored for up to 14 days when processing is performed with the ACP 215 system with resuspension of deglycerolized RBCs in AS-3.
    MeSH term(s) Adenine ; Blood Component Removal ; Blood Preservation ; Citrates ; Cryopreservation/methods ; Erythrocyte Transfusion ; Erythrocytes ; Glucose ; Glycerol/administration & dosage ; Humans ; Leukocytes ; Mannitol ; Phosphates ; Sodium Chloride ; Time Factors
    Chemical Substances ADSOL ; AS-3 preservative solution ; Citrates ; Phosphates ; Mannitol (3OWL53L36A) ; Sodium Chloride (451W47IQ8X) ; Glucose (IY9XDZ35W2) ; Adenine (JAC85A2161) ; Glycerol (PDC6A3C0OX)
    Language English
    Publishing date 2004-11
    Publishing country United States
    Document type Journal Article
    ZDB-ID 208417-x
    ISSN 1537-2995 ; 0041-1132
    ISSN (online) 1537-2995
    ISSN 0041-1132
    DOI 10.1111/j.1537-2995.2004.04101.x
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top